Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 62 Rectal Neoplasms 49 Breast Neoplasms 48 Stomach Neoplasms 37 Esophageal Neoplasms 35 Colorectal Neoplasms 33 Lung Neoplasms 30 Squamous Cell Carcinoma of Head and Neck 28 Pancreatic Neoplasms 25 Brain Neoplasms 25 Glioblastoma 23 Neoplasms 22 Sarcoma 21 Neoplasm Metastasis 20 Carcinoma, Hepatocellular 18 Head and Neck Neoplasms 17 Glioma 16 Esophageal Squamous Cell Carcinoma 16 Colonic Neoplasms 13 Recurrence 11 Ovarian Neoplasms 10 Oropharyngeal Neoplasms 10 Melanoma 10 Astrocytoma 10 Adenocarcinoma Of Esophagus 10 Thyroid Neoplasms 9 Hypopharyngeal Neoplasms 9 Prostatic Neoplasms 8 Laryngeal Neoplasms 8 Central Nervous System Neoplasms 8

Interventions

Ipilimumab 17 Nivolumab 15 incomplete Freund's adjuvant 8 Cyclophosphamide 7 CTLA-4 Antigen 7 pembrolizumab 6 Ranibizumab 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 tebentafusp 4 Temozolomide 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 Bevacizumab 4 fludarabine phosphate 3 fludarabine 3 aflibercept 3 Thalidomide 3 Sunitinib 3 Specimen Handling 3 MAGEA3 protein, human 3 Interleukin-2 3 130-nm albumin-bound paclitaxel 3 relatlimab 2 olaparib 2 montanide ISA 51 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Surgical Procedures, Operative × Clear all

NCT05402059 2022-06-15

ISABELLA

MelanomaPRO, Russia

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡